Donald E. Fetterolf, MD, discusses the major advantage of amniotic membrane therapy: the ability of the allografts to attract stem cells to the region of the wound in order to rebuild damaged tissues.
Jeff Hutchins, PhD, discusses current clinical trials that are investigating whether some patients with non-small cell lung cancer may qualify for an immune-oncology therapy treatment regimen that is...
Why is adopting healthier behaviors so difficult for many of us? Health equity leader and orthopedic surgeon Mary O’Connor, MD, explores what contributes to our health and well-being, as well as the power...
